{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-135823","form_type":"8-K","ticker":"CLSDQ","cik":"0001539029","company_name":"Clearside Biomedical, Inc.","filed_at":"2024-12-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.742013+00:00","generated_at":"2026-05-29T04:02:59.123125+00:00","sec_items":["7.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Clearside updates corporate presentation; specifics in slides 31-37 not visible in filing text","bullets":["Filing furnishes updated investor deck for analyst and investor meetings.","Slides 31 through 37 incorporated by reference under Item 8.01.","Exhibit 99.1 only shows title page; material details cannot be extracted from provided text."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-135823","json":"https://secwatch.observer/filing/0000950170-24-135823.json","markdown":"https://secwatch.observer/filing/0000950170-24-135823.md","text":"https://secwatch.observer/filing/0000950170-24-135823.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1539029/000095017024135823/0000950170-24-135823-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1539029/000095017024135823/clsd-20241212.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T04:02:59.123125+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}